Tanja Waldmann

The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils.

Structure-specific binding of the proto-oncogene protein DEK to DNA.

Functional domains of the ubiquitous chromatin protein DEK.

The DEK protein--an abundant and ubiquitous constituent of mammalian chromatin.

The SAF-box domain of chromatin protein DEK.

HP1 binds specifically to Lys26-methylated histone H1.4, whereas simultaneous Ser27 phosphorylation blocks HP1 binding.

Chromatin dynamics during epigenetic reprogramming in the mouse germ line.

Arginine methylation of the B cell antigen receptor promotes differentiation.

Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing.

Histone H2A C-terminus regulates chromatin dynamics, remodeling, and histone H1 binding.

Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line.

The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity.

Methylation of H2AR29 is a novel repressive PRMT6 target.

Extensive transcriptional regulation of chromatin modifiers during human neurodevelopment.

Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome.

Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach.

Targeting histone modifications--epigenetics in cancer.

90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.

Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells.

From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects.

Lineage-specific regulation of epigenetic modifier genes in human liver and brain.

Toxicogenomics directory of chemically exposed human hepatocytes.